Cover Image

Irbesartan Prevents Metabolic Syndrome in Rats via Activation of Peroxisome Proliferator-Activated Receptor γ

Abstract.: Irbesartan, an angiotensin-receptor blocker, is a known agonist of peroxisome proliferator-activated receptor (PPAR) γ. In this study, thirteen-week-old spontaneously hypertensive (SHR)/NDmcr-cp rats, representing a genetic model of metabolic syndrome, were treated daily with placebo, irb...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shinji Takai (Author), Denan Jin (Author), Mizuo Miyazaki (Author)
Format:	Book
Published:	Elsevier, 2011-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A Single Treatment With a Specific Chymase Inhibitor, TY-51184, Prevents Vascular Proliferation in Canine Grafted Veins
by: Shinji Takai, et al.
Published: (2004)

Peroxisome Proliferator-Activated Receptor γ 2 Modulates Late-Pregnancy Homeostatic Metabolic Adaptations
by: Yurena Vivas, et al.
Published: (2016)

New Approaches to Blockade of the Renin-Angiotensin-Aldosterone System: Chymase as an Important Target to Prevent Organ Damage
by: Shinji Takai, et al.
Published: (2010)

Multiple Mechanisms for the Action of Chymase Inhibitors
by: Shinji Takai, et al.
Published: (2012)

Assessment of total, ligand-induced peroxisome proliferator activated receptor γ ligand activity in serum
by: Lariah Edwards, et al.
Published: (2019)

Peroxisome Proliferator-Activated Receptor Targets for the Treatment of Metabolic Diseases
by: Francisco A. Monsalve, et al.
Published: (2013)

Haplotype Analysis of Peroxisome Proliferator-activated Receptor γ Gene Polymorphisms and the Lipoprotein (a) Level
by: Chao SHEN, et al.
Published: (2018)

Nuclear Receptors as Targets for Drug Development: Peroxisome Proliferator-Activated Receptor γ in Mast Cells: Its Roles in Proliferation and Differentiation
by: Kazutaka Maeyama, et al.
Published: (2005)

Zafirlukast Is a Dual Modulator of Human Soluble Epoxide Hydrolase and Peroxisome Proliferator-Activated Receptor γ
by: Tamara Göbel, et al.
Published: (2019)

Activation of Peroxisome Proliferator-Activated Receptor γ by Rosiglitazone Inhibits Lipopolysaccharide-Induced Release of High Mobility Group Box 1
by: Jung Seok Hwang, et al.
Published: (2012)

Metabolic adaptation to intermittent fasting is independent of peroxisome proliferator-activated receptor alpha
by: Guolin Li, et al.
Published: (2018)

Significance of Matrix Metalloproteinase-9 Inhibition by Imidapril for Prevention of Abdominal Aortic Aneurysms in Angiotensin II Type 1 Receptor-Knockout Mice
by: Shinji Takai, et al.
Published: (2013)

Estimation of peroxisome proliferators - activated receptor γ gene expression in inflammatory skin diseases: atopic dermatitis and psoriasis
by: Doaa Mahgoub, et al.
Published: (2014)

Implication of Peroxisome Proliferator-Activated Receptor γ and Proinflammatory Cytokines in Gastric Carcinogenesis: Link to Helicobacter pylori-Infection
by: Peter C. Konturek, et al.
Published: (2004)

The Role of Peroxisome Proliferator-Activated Receptors in Kidney Diseases
by: Jianjun Gao, et al.
Published: (2022)

Rational screening of peroxisome proliferator-activated receptor-γ agonists from natural products: potential therapeutics for heart failure
by: Rui Chen, et al.
Published: (2017)

Baohuoside I Inhibits Tumor Angiogenesis in Multiple Myeloma via the Peroxisome Proliferator-Activated Receptor γ/Vascular Endothelial Growth Factor Signaling Pathway
by: Ying Chen, et al.
Published: (2022)

Chymase Inhibition Provides Pancreatic Islet Protection in Hamsters With Streptozotocin-Induced Diabetes
by: Shinji Takai, et al.
Published: (2009)

Insulin Sensitization by a Novel Partial Peroxisome Proliferator-Activated Receptor γ Agonist With Protein Tyrosine Phosphatase 1B Inhibitory Activity in Experimental Osteoporotic Rats
by: Masahiro Kubo, et al.
Published: (2014)

The role of peroxisome proliferator-activated receptors in the tumor microenvironment, tumor cell metabolism, and anticancer therapy
by: Jiaao Sun, et al.
Published: (2023)

Potent Antidiabetic Effects of Rivoglitazone, a Novel Peroxisome Proliferator-Activated Receptor-γ Agonist, in Obese Diabetic Rodent Models
by: Shoichi Kanda, et al.
Published: (2009)

Peroxisomal proliferator activated receptor-γ deficiency in a Canadian kindred with familial partial lipodystrophy type 3 (FPLD3)
by: Cao Henian, et al.
Published: (2006)

The Activation of Peroxisome Proliferator-activated Receptor γ Enhances Insulin Signaling Pathways Via Up-regulating Chemerin Expression in High Glucose Treated HTR-8/SVneo Cells
by: Xuan Zhou, et al.
Published: (2020)

Danhong Inhibits Oxidized Low-Density Lipoprotein-Induced Immune Maturation of Dentritic Cells via a Peroxisome Proliferator Activated Receptor γ-Mediated Pathway
by: Hongying Liu, et al.
Published: (2012)

Inhibition of Peroxisome Proliferator-Activated Receptor γ Promotes Tumorigenesis Through Activation of the β-Catenin / T Cell Factor (TCF) Pathway in the Mouse Intestine
by: Toshio Fujisawa, et al.
Published: (2008)

The function of peroxisome proliferator-activated receptors PPAR-γ and PPAR-δ in Mycobacterium leprae-induced foam cell formation in host macrophages.
by: Yuqian Luo, et al.
Published: (2020)

Stimulator of interferon genes promotes diabetic sarcopenia by targeting peroxisome proliferator activated receptors γ degradation and inhibiting fatty acid oxidation
by: Sen‐bo Yan, et al.
Published: (2023)

Nuclear Receptors as Targets for Drug Development: Crosstalk Between Peroxisome Proliferator-Activated Receptor γ and Cytokines in Bone Marrow-Derived Mesenchymal Stem Cells
by: Ichiro Takada, et al.
Published: (2005)

Induction of peroxisome proliferator activated receptor γ (PPARγ) mediated gene expression and inhibition of induced nitric oxide production by Maerua subcordata (Gilg) DeWolf
by: Mebrahtom Gebrelibanos Hiben, et al.
Published: (2020)

Peroxisome proliferator-activated receptors regulate the progression and treatment of gastrointestinal cancers
by: Min Zhang, et al.
Published: (2023)

Repurposing Peroxisome Proliferator-Activated Receptor Agonists in Neurological and Psychiatric Disorders
by: Claudia Sagheddu, et al.
Published: (2021)

Peroxisome Proliferator-Activated Receptor-Gamma Reduces ER Stress and Inflammation via Targeting NGBR Expression
by: Jialing Ma, et al.
Published: (2022)

Tissue Angiotensin II Generating System by Angiotensin-Converting Enzyme and Chymase
by: Mizuo Miyazaki, et al.
Published: (2006)

The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases
by: Sandeep Tyagi, et al.
Published: (2011)

Fenretinide inhibits macrophage inflammatory mediators and controls hypertension in spontaneously hypertensive rats via the peroxisome proliferator-activated receptor gamma pathway
by: Lin CH, et al.
Published: (2016)

Curcumin attenuates beta-amyloid-induced neuroinflammation via activation of peroxisome proliferator-activated receptor-gamma function in a rat model of Alzheimer's disease
by: Zun-Jing Liu, et al.
Published: (2016)

Initiation of the expression of peroxisome proliferator - activated receptor gamma (PPAR gamma) in the rat ovary and the role of FSH
by: Sairam M Ram, et al.
Published: (2009)

Peroxisome Proliferator-Activated Receptor γ (PPARγ ) Suppresses Colonic Epithelial Cell Turnover and Colon Carcinogenesis Through Inhibition of the β-Catenin / T Cell Factor (TCF) Pathway
by: Toshio Fujisawa, et al.
Published: (2008)

Peroxisome Proliferator-Activated Receptors (PPARs) and Oxidative Stress in Physiological Conditions and in Cancer
by: Giuliana Muzio, et al.
Published: (2021)

Salidroside Ameliorates Cardiomyocyte Hypertrophy by Upregulating Peroxisome Proliferator-Activated Receptor-α
by: Hui Gao, et al.
Published: (2022)